Cargando…
可切除非小细胞肺癌新辅助免疫治疗的进展
Resectable non-small cell lung cancer (NSCLC) is currently considered as a potentially curable disease. Surgery is still the main treatment mode for resectable NSCLC, but quite a few patients will have local recurrence and distant metastasis after surgery. Therefore, preoperative and postoperative a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260379/ https://www.ncbi.nlm.nih.gov/pubmed/32283581 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.07 |